cagrisema cagrilintide semaglutide phase 3 obesity drug: what the data shows The Obesity Wars of 2026

This is because semaglutide is metabolized and excreted through the kidneys, producing metabolites that drug tests are not designed to detect

Lee et al.'s simpler topical approach produced more modest but still significant results suggesting a spectrum from basic topical use to advanced clinical delivery

Cells were cultured for 7 days, replacing the culture medium (with or without hHGF or dimeric macrocycle) every second day

In recent months, access to GLP-1 medications for weight management has been dealt a major setback, with insurers like Blue Cross Blue Shield announcing they will drop coverage for anti-obesity drugs in Massachusetts